Martin Kolb is the Jack Gauldie Boehringer Ingelheim Chair in Interstitial Lung Disease and the Director of the Division of Respirology, McMaster University, Hamilton, ON. His major research interests are fibrotic lung disease, with a particular interest in the role of growth factors, matrix abnormalities and pulmonary vessel remodeling in disease progression. He leads activities in biomarker development for lung fibrosis, and is a Principal Investigator and steering committee member in numerous ILD clinical trials. Professor Kolb has authored over 290 peer-reviewed publications on different basic science and clinical topics with an H-Factor above 74. He was the Chief-Editor of the European Respiratory Journal (2018-2022) and currently is the journal’s Section Editor for Interstitial Lung Disease. He is also an editorial board member of several journals, including American Journal of Respiratory and Critical Care Medicine and European Respiratory Review and Respirology.